Even though the levels of tumor growth gradually approached the levels seen with tumor alone implanted mice at the days 18-24, we could still see a lower tumor growth with sNK+anti-PD-1 antibody treated group as compared to sNK treated group, and both groups had on average lower growth when compared to those from tumor alone implanted mice (Figures 7D, S9B). The gene discussed is PLK2; the disease is neoplasm.